Star Scientific plans to introduce a new product
- November 5, 2009
Star Scientific Inc. plans to introduce a nutraceutical in 2010 that would help adult smokers maintain a nicotine-free metabolism.
The Petersburg-based company announced today that CigRx, developed by its subsidiary Rock Creek Pharmaceuticals, will be marketed and sold in partnership with inVentiv Health, Inc. The Somerset, N.J., company, which provides commercialization services to the pharmaceutical and health care industries, has sales and marketing capabilities in 40 countries.
“Cigarette smoking is the leading cause of preventable death in the world,” Jonnie R. Williams, Star’s CEO, said in a statement. “However, the global cigarette business, which now exceeds $300 billion, continues to grow. Our goal is to make CigRx available to adult smothers worldwide who wish to maintain a nicotine-free metabolism.”
The product, a dietary supplement, does not contain nicotine. It would be taken orally like a throat lozenge, dissolved and swallowed, according to Sara Machir, Star’s vice president of communications and investor relations.CigRx would be directed at people who are trying to quit or who already are abstaining from smoking, she said.